Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Quick Links

Call customer care

Indications, safety, and warnings

Polaris™ Loop Ureteral Stents

Brief Summary Document - HCP

Product

Polaris™ Loop Ureteral Stents: IFU 51413324-01A


Rx statement

CAUTION: Federal Law (USA) restricts this device to sale by or on the order of a physician.

This device is restricted to use by or under the supervision of physicians trained in endoscopic urological biopsy procedures.

Prior to use, please refer to all applicable “Instructions for Use” for more information on Intended Use/Indications for Use, Contraindications, Warnings, Precautions, Potential Adverse Events, and Operator’s Instructions.

Intended use/Indications for use

The Ureteral Stents are intended to facilitate urinary drainage from the kidney to the bladder via placement endoscopically or fluoroscopically by a trained physician.

Contraindications

Antegrade placement.

Warnings

None known.

Precautions

Not adhering to the following precautions could result in patient injury:

  • During cystoscopic placement the Polaris Loop Stent requires a 12F (4.0 mm) or greater bridgeport in conjunction with a 19.5F (6.5 mm) or larger sheath.
  • During stent removal it is recommended to grasp both loops prior to extracting the stent.
  • Retrieval line (suture) indwelling time should not exceed fourteen (14) days to avoid possible line encrustation.
  • Evaluate the stent periodically to ensure the stent is draining adequately and to observe for possible complications.
    • Note: Stent indwelling time (with retrieval line (suture) removed) should not exceed 365 days*.
    • Evaluate the stent on or before 90 days after placement, and at least every 90 days thereafter if long term use is indicated.

Refer to Instructions for Use for all applicable information on Precautions.

*Data on file

Potential adverse events

Adverse events associated with retrograde or antegrade positioned indwelling ureteral stents include but are not limited to:

  • Allergic Reaction
  • Avulsion
  • Discomfort
  • Dislodgement
  • Edema
  • Encrustation
  • Erosion
  • Extravasation
  • Fistula
  • Hematoma
  • Hematuria
  • Hemorrhage
  • Hydronephrosis
  • Infection
    • Peritonitis
    • Sepsis
    • Urinary Tract Infection
  • Inflammation
  • Loss of Renal Function
  • Migration
  • Obstruction
  • Occlusion
  • Pain
  • Perforation
  • Reflux, Genitourinary (GU) (includes Ureteral Reflux)
  • Stone Formation
  • Tissue Damage
  • Unretrieved Device Fragment
  • Urinary Symptoms
    • Dysuria
    • Frequency
    • Incontinence
    • Nocturia
    • Urgency

Adverse events may require additional medical or surgical intervention.